Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 4.17% | 139.76 | 0.7% | $2263.93m | |
| PFE | Pfizer Inc. | 2.65% | 34.53 | 0.9% | $1462.96m | |
| MRK | Merck & Co., Inc. | 5.36% | 80.34 | 0.7% | $1347.05m | |
| ABBV | AbbVie, Inc. | 2.99% | 75.56 | 2.3% | $1227.94m | |
| BMY | Bristol-Myers Squibb Co. | 3.98% | 57.74 | 1.0% | $1157.01m | |
| LLY | Eli Lilly & Co. | 1.17% | 141.30 | 1.1% | $872.78m | |
| NVS | Novartis AG | 2.58% | 85.80 | 0.2% | $305.75m | |
| AZN | AstraZeneca Plc | 0.77% | 44.30 | 1.2% | $301.56m | |
| GSK | GlaxoSmithKline Plc | 2.10% | 37.92 | 0.2% | $258.31m | |
| SNY | Sanofi | 2.88% | 46.12 | 0.2% | $176.94m | |
| NVO | Novo Nordisk A/S | 1.40% | 60.68 | 0.1% | $171.78m | |
| FTSV | Forty Seven, Inc. | 0.05% | 95.51 | 0.0% | $152.45m | |
| BHC | Bausch Health Cos., Inc. | 9.77% | 14.61 | 0.0% | $97.57m | |
| RGEN | Repligen Corp. | 2.55% | 100.71 | 7.1% | $73.73m | |
| RETA | Reata Pharmaceuticals, Inc. | 7.32% | 138.29 | 3.4% | $66.79m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.